Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies. Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest, sets timelines for review and approval, and uses an expert review panel (ERP) to make final grant decisions. Organizations are invited to submit an application addressing the specific gaps in practice as outlined in the specific RFP.
The British Society for Antimicrobial Chemotherpay (BSAC) is a learned professional organisation providing a portfolio of global education on infection related topics and a leading influencer of responsible antimicrobial use globally.
The purpose of this RFP is to solicit programs that have identified a resource limitation within their healthcare organization that impacts establishment of a holistic and sustainable antimicrobial stewardship (AMS) program. The RFP will support delivery, to successful applicant institutions, of a programme of work to support the development of local AMS programs and will culminate with accreditation of centres and lead to a network of AMS Centres of Excellence across the world that can share learning within their region.
It is our intent to support submissions that focus on establishing or improving sustainable and holistic hospital AMS programs in resource-limited health facilities and / or in support of underserved populations.
Multi-disciplinary collaborations are encouraged, and all partners must have a relevant role.
Full Proposal Deadline: April 6, 2022
Geographic scope: Global, covering resource limited settings within both High-Income Country (HIC) and Low- and Middle-Income country (LMIC) settings
• Only institutions are eligible to receive grants, not individuals or medical practice groups. • Institution would ideally be part of a network of hospitals or institutions of a healthcare provider or within a region to ensure potential for dissemination of learnings/best practice and to achieve broadest impact. • Institution must have identified a resource limitation(s) in their healthcare organisation that negatively impact on the ability to establish a holistic and sustainable AMS progam. • Institution must have information/data available relating to national and local structures and processes that demonstrates their current position with respect to AMS. • The Lead applicant must have a medical or postdoctoral degree (MD, PhD, or equivalent), an advanced nursing degree (BSN with a MS/PhD or Doctorate of Nursing Practice), or a degree in Pharmacy, Microbiology or Epidemiology
The estimated value of the supported program of work to be delivered in partnership with successful institutions will be approximately $75,000 dependent on the size and requirements of your institution. This value is delivered through the programme of work provided to institutions during the duration of the project.